Skip to Content
myAACR
Donate Today

Progress Against Cancer

Home » Patients, Caregivers, and Advocates » Progress Against Cancer » Progress Against Cancer » Page 2

Recent Progress: FDA Approvals

Taking Aim at a Rare Type of Thyroid Cancer

Taking Aim at a Rare Type of Thyroid Cancer

The FDA has expanded the approval of a molecularly targeted therapeutic to treat certain pediatric and adult patients with medullary thyroid cancer.  The U.S. Food and Drug Administration has approved pralsetinib (Gavreto) to treat certain adult and pediatric patients age...